World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
61
Citations
12828
World Ranking
11381
National Ranking
815

Rolf Kaiser publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Rolf Kaiser sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 362 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Rolf Kaiser D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Rolf Kaiser sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 61 D-Index — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Rolf Kaiser is affiliated with the University of Cologne in Germany. Their primary field of study is Medicine, with a focus on Infectious Diseases, Epidemiology, and Virology among other related subfields. They have contributed extensively to topics such as HIV research and treatment, SARS-CoV-2 and COVID-19 research, and respiratory viral infections.

Their published work spans a range of subjects including HIV/AIDS drug development, epidemiological interventions, molecular biology aspects of viral infections, and hepatology. Key main topics covered in their research include:

  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • SARS-CoV-2 and COVID-19 Research
  • Respiratory viral infections research
  • SARS-CoV-2 detection and testing
  • Herpesvirus Infections and Treatments

Rolf Kaiser's frequent coauthors indicate collaboration within a focused research network, including:

  • Eva Heger
  • Florian Klein
  • Elena Knops
  • Veronica Di Cristanziano
  • Maurizio Zazzi

Their research has been published multiple times in notable scientific venues. The most frequent publication venues include:

  • Viruses
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Infection
  • BMC Public Health
  • Journal of Clinical Virology

Among their recent and cited papers are the following:

  • In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation, 2023, Nature Medicine
  • RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients, 2020, Viruses
  • Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting, 2021, European Journal of Clinical Microbiology & Infectious Diseases
  • Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization, 2022, Immunity
  • Pooled RT-qPCR testing for SARS-CoV-2 surveillance in schools - a cluster randomised trial, 2021, EClinicalMedicine

Best Publications

  • Bioinformatics prediction of HIV coreceptor usage

    Thomas Lengauer;Oliver Sander;Saleta Sierra;Alexander Thielen

  • Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes

    Niko Beerenwinkel;Martin Däumer;Mark Oette;Klaus Korn

  • European guidelines on the clinical management of HIV-1 tropism testing

    L.P.R. Vandekerckhove;Annemarie Wensing;Rolf Kaiser;F. Brun-Vézinet

  • HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice

    Joshua A. Horwitz;Ariel Halper-Stromberg;Hugo Mouquet;Alexander D. Gitlin

  • Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype

    Niko Beerenwinkel;Barbara Schmidt;Hauke Walter;Rolf Kaiser

  • Basics of the virology of HIV-1 and its replication.

    Saleta Sierra;Bernd Kupfer;Rolf Kaiser

  • T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti- hepatitis C virus-positive blood donors without viremi

    M Lechmann;H G Ihlenfeldt;I Braunschweiger;G Giers

  • Predicting HIV coreceptor usage on the basis of genetic and clinical covariates

    To Bias Sing;Andrew J. Low;Niko Beerenwinkel;Oliver Sander

  • Learning multiple evolutionary pathways from cross-sectional data

    Niko Beerenwinkel;Jörg Rahnenführer;Martin Däumer;Daniel Hoffmann

  • Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

    Alessandro Cozzi-Lepri;Marc Noguera-Julian;Francesca Di Giallonardo;Rob Schuurman

  • Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing.

    Mark Oette;Rolf Kaiser;Martin Däumer;Ruth Petch

  • Acute epididymitis revisited: impact of molecular diagnostics on etiology and contemporary guideline recommendations.

    Adrian Pilatz;Hamid Hossain;Rolf Kaiser;Annette Mankertz

  • Computational methods for the design of effective therapies against drug resistant HIV strains

    Niko Beerenwinkel;Tobias Sing;Thomas Lengauer;Jörg Rahnenführer

  • Geno2pheno[HCV] - A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents.

    Prabhav Kalaghatgi;Anna Maria Sikorski;Elena Knops;Daniel Rupp

  • Severe Pneumonia and Human Bocavirus in Adult

    Bernd Kupfer;Jörg Vehreschild;Oliver Cornely;Rolf Kaiser

  • Phase I Safety, Pharmacokinetic, and Biomarker Study of BIBF 1120, an Oral Triple Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors

    Isamu Okamoto;Hiroyasu Kaneda;Taroh Satoh;Wataru Okamoto

  • Estimating HIV Evolutionary Pathways and the Genetic Barrier to Drug Resistance

    Niko Beerenwinkel;Martin Däumer;Tobias Sing;Jörg Rahnenführer

  • Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models

    Mattia C. F. Prosperi;Mattia C. F. Prosperi;Michal Rosen-Zvi;André Altmann;Maurizio Zazzi

  • Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication.

    J P Kleim;R Bender;R Kirsch;C Meichsner

  • Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient

    Sabine Awerkiew;Martin Däumer;Marcel Reiser;Ulrike C. Wend

Frequent Co-Authors

Thomas Lengauer
Thomas Lengauer Max Planck Institute for Informatics
Maurizio Zazzi
Maurizio Zazzi University of Siena
Herbert Pfister
Herbert Pfister University of Cologne
Anders Sönnerborg
Anders Sönnerborg Karolinska Institute
Gerd Fätkenheuer
Gerd Fätkenheuer University of Cologne
Anne-Mieke Vandamme
Anne-Mieke Vandamme Rega Institute for Medical Research
Joachim Selbig
Joachim Selbig Max Planck Society
Jürgen K. Rockstroh
Jürgen K. Rockstroh University Hospital Bonn
Dieter Häussinger
Dieter Häussinger Heinrich Heine University Düsseldorf

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA can open doors to a variety of healthcare and science-related careers. With the rise of digital education, students have more flexible options to advance their knowledge and skills online. For those interested in leadership, fast online master's in healthcare management programs prepare graduates for senior roles in hospitals and other medical organizations.

Mental health is another rapidly growing field. Aspiring nurse practitioners can enroll in pmhnp programs to specialize in psychiatric care and support patients with mental health needs. If nutrition and preventative healthcare appeal to you, accelerated dietitian programs offer pathways into roles like registered dietitian or nutritionist.

Budget-conscious students may also consider a cheap online mba healthcare administration to gain both scientific insights and business expertise. Exploring these online degrees can help biology and biochemistry students unlock diverse, rewarding healthcare and science careers.

Best Scientists Citing Rolf Kaiser

Trending Scientists

Recently Published Articles